Journal of Viral Hepatitis

Article	Citations
Issue Information	50
Age, ethnicity and proximity to clinic determine retention in care of chronic hepatitis B patients	41
Response to letter to editor: Potential impact of Helicobacter pylori infection on hepatic steatosis and metabolic risk factors among patients with chronic hepatitis B	39
	31
Issue Information	26
Retraction	26
Bocavirus Infection as a Potential Trigger for Hepatic Injury in Children	23
Correlates of chronic hepatitis B virus infection in the general adult population of China: Systematic review and meta‐analysis	23
Screening, Prevalence and Management of Chronic Viral Hepatitis C in Mental Health Setting: Towards the Eradication of A Forgotten Reservoir	22
Single‐Cell Transcriptome Identifies a Proinflammatory B‐Cell Subset in Hepatitis B Virus Associated Acute‐on‐Chronic Liver Failure	21
Investigating rates and risk factors for hepatitis C virus reinfection in people receiving antiviral treatment in England	20
Falling treatment uptake in the hepatitis C care cascade is a growing threat to achieving elimination	20
Baseline Alpha‐Fetoprotein Elevation and the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B: A Multicentre Cohort Study	20
	19
A morphometric analysis of hepatitis B subviral particles shows no correlation of filament proportion and length with clinical stage and genotype	19
Cover Image	19
Efficacy of hepatitis C virus eradication after curative treatment for hepatocellular carcinoma in patients with advanced hepatocellular carcinoma and decreased hepatic functional reserve: A nationwid	18
Depletion of circ_0088046 suppressed cell growth and motility of hepatocellular carcinoma via circ_0088046‐miR‐1299‐RTKN2 ceRNA pathway	17
Kinetics of quantitative hepatitis B surface antigen in patients with rheumatic disease and chronic hepatitis B receiving biologic agents	17
	16
	16
The role of serum sphingolipids as potential biomarkers of non‐response to direct acting antiviral therapy in chronic hepatitis C virus infection	16
Issue Information	15
	15
Issue Information	15

Evaluating and communicating hepatitis C cascades of care data in Tayside, Scotland: A journey towards elimination	15
	15
Cover image	14
Follow‐up evaluation of patients with liver test abnormalities detected during SARS‐CoV2 infection	14
Quantitative HBsAg an unreliable marker for diagnosis and disease progression in genotype F chronic HBeAg‐negative infections	14
Issue Information	13
Kinetics of serum O‐glycosylated M‐hepatitis B surface antigen with hepatocellular carcinoma history and nucleos(t)ide analogue therapy in hepatitis B patients	13
Hepatitis C virus eradication ameliorates the prognosis of advanced hepatocellular carcinoma treated with sorafenib	13
Sequence characterization of extracellular HBV RNA in patient plasma	13
A new algorithm shows superior ability to discriminate liver fibrosis stages in chronic hepatitis C	13
Patient‐reported experiences with direct acting antiviral therapy in an integrated model of hepatitis C care in homeless shelters	13
Consider more about risk scores for predicting hepatocellular carcinoma in patients with chronic hepatitis B	13
Hepatitis B surface antigen kinetics after discontinuation of and retreatment with oral antivirals in non‐cirrhotic HBeAg‐positive chronic hepatitis B	12
240‐week entecavir maleate treatment in Chinese chronic hepatitis B predominantly genotype B or C	12
‘There's too much power in this number. It's freaking the whole response out’: The views of key informants on evidence and targets to achieve hepatitis C elimination goals in Australia	12
Assessing risk scores for predicting hepatocellular carcinoma in Thai patients with chronic hepatitis B	12
International disease burden of acute viral hepatitis among adolescents and young adults: An observational study	12
Poor linkage to care may compromise the Brazilian plan for hepatitis C elimination	11
	11
Different mutation rates in the basal core promoter and precore regions between hepatitis B virus subgenotype F1b clusters	11
	11
Sustained and cumulative impact of an electronic medical record‐based alert on a hepatitis C birth cohort screening programme	10
Evaluation of the hepatitis C cascade of care among people living with HIV in New South Wales, Australia: A data linkage study	10
Post‐HCV cure self‐reported changes in physical activity, eating behaviours, and fatigue in people living with HIV (ANRS CO13 HEPAVIH)	10
Prevalence of hepatitis B virus (HBV) and latent tuberculosis co‐infection and risk of drug‐induced liver injury across two large HBV cohorts in the United	10
Persistence of antibodies 5 years after hepatitis B vaccination in preterm birth children: A retrospective cohort study using real‐world data	10
Serum HBV RNA predicts HBeAg clearance and seroconversion in patients with chronic hepatitis B treated with nucleos(t)ide analogues	10
Issue Information	10
Issue Information	10
Hepatitis A occurrence and outbreaks in Europe over the past two decades: A systematic review	10
Australian Community Pharmacists' Preparedness to Offer and Discuss Hepatitis C Testing and Treatment With Pharmacy Clients: A Representative Cross‐Sectional Survey	9
Long‐Term Effects of Direct‐Acting Antivirals on Hepatitis C: Trends in Liver Disease–Related Hospitalisations in Italy	9
A novel multi‐epitope peptide vaccine candidate targeting hepatitis E virus: An in silico approach	9
Severe Liver‐Related Outcomes in Patients With Hepatitis Delta: Results From a Multi‐Ethnic Multicenter Long‐Term Follow‐Up Study	9
Evaluating the renal safety of tenofovir disoproxil fumarate in hepatitis B patients without chronic kidney disease	9
Implementation of a re‐linkage to care strategy in patients with chronic hepatitis C who were lost to follow‐up in Latin America	9
Optimization of the Use of APRI and FIB‐4 for Ruling Out Liver Cirrhosis in Chronic Hepatitis B Patients With Normal Alanine Aminotransferase	9
Persistence of immunity against hepatitis A in Brazilian children vaccinated with a single dose of inactivated virus vaccine	9
Hepatitis B virus–induced hepatocarcinogenesis: A virological and oncological perspective	9
Contextual and individual factors associated with knowledge, awareness and attitude on liver diseases: A large‐scale Asian study	8
Issue Information	8
Prevalence and characteristics of hepatitis C virus infection detected by extended screening of working‐age adults in Madrid (Spain)	8
Bulevirtide‐based treatment strategies for chronic hepatitis delta: A review	8
The cost‐effectiveness of case‐finding strategies for achieving hepatitis C elimination among men who have sex with men in the UK	8
Large‐scale screening is not useful for identifying individuals with hepatitis B or C virus infection: A prospective Swiss study	8
Prevalence, clinical and virological characteristics and short‐term prognosis of hepatitis delta infection among patients with HIV/HBV in Nouakchott, Mauritania	8
Reply to: ‘Long‐term prognosis with or without nucleot(s)ide analogue therapy in hepatitis B virus‐related decompensated cirrhosis’	8
Cost‐effectiveness analysis of an active search to retrieve HCV patients lost to follow‐up (RELINK‐C strategy) and the impact of COVID‐19	8
A cross‐sectional study of hepatitis C prevalence and correlates among persons who inject drugs in rural and non‐rural communities	8
Hepatitis C prevalence and elimination planning in Pakistan, a bottom‐up approach accounting for provincial variation	8

	8
Classification and survival prediction in early‐stage cirrhosis by gene expression profiling	8
Efficacy and safety of direct‐acting antiviral therapy for hepatitis C virus in elderly patients (≥65 years old): A systematic review and meta‐analysis	7
Genetic substructure and host‐specific natural selection trend across vaccine‐candidate ORF‐2 capsid protein of hepatitis‐E virus	7
Self‐reported hepatitis B testing among noninstitutionalized adults in the United States before the implementation of universal screening, 2013–2017: A nationwide population‐based study	7
Hepatitis A hospitalisations in the United States and risk factors for inpatient mortality: A nationwide population study, 1998–2020	7
Internet‐guided HCV‐RNA testing: A promising tool to achieve hepatitis C micro‐elimination among men who have sex with men	7
Outcomes of a 1‐Year Pilot Study Implementing Universal Hepatitis Delta Virus Testing Among Veterans With Chronic Hepatitis B	7
The benefits of gene therapy in people with haemophilia	7
The impact of the first, second and third waves of covid‐19 on hepatitis B and C testing in Ontario, Canada	7
Impact of recent drug use on the efficacy of elbasvir/grazoprevir for HCV‐infected people on opioid agonist therapy	7
External validation of CAGE‐B and SAGE‐B scores for Asian chronic hepatitis B patients with well‐controlled viremia by antivirals	7
Closing the hepatitis C treatment gap: United States strategies to improve retention in care	7
Long‐term persistence of anti‐HAV antibody conferred by a single dose of live‐attenuated hepatitis A vaccine: Results from 17‐year follow‐up	7
Evaluation of Knowledge, Attitudes and Practices for Hepatitis B Virus Infection Among Primary Healthcare Physicians in Georgia	7
High prevalence of hepatitis B virus among MSM living with HIV in India	7
Estimating the attributable fraction of cirrhosis and hepatocellular carcinoma due to hepatitis B and C	7
Clinical Prevalence of Hepatitis D Virus Among Hepatitis B Patients in Sulaymaniyah Governorate, Northern Iraq	7
Immunogenicity of a Birth Dose of Hepatitis B Vaccine in Kinshasa, Democratic Republic of Congo: A Randomised, Controlled Trial	6
Hepatocellular carcinoma among patients with chronic hepatitis B in the indeterminate phase	6
Interaction Between Hepatitis B, Hepatitis C and Alcohol in the Development of Hepatocellular Carcinoma: A Systematic Review and Meta‐Analysis	6
Global prevalence of occult hepatitis B: A systematic review and meta‐analysis	6
Individual Heterogeneity and Trends in Hepatitis C Infection Risk Among People Who Inject Drugs: A Longitudinal Analysis	6
Impact of HBV Infection in Couples on In Vitro Fertilisation‐Embryo Transfer Outcomes and Clinical Characteristics of Newborns: A Retrospective Study Based on 3900 Infertile Couples	6
Letter in response: Psychiatrists can treat hepatitis C	6
Hepatitis E Infection in Immunocompromised Patients Previously Treated With Rituximab	6
Global elimination of HBV: Is it really achievable?	6
Changes in Serum Rheumatoid Factor Following Eradication of Hepatitis C Virus Infection With Interferon or Direct Antiviral Therapy	6
The impact of point‐of‐care hepatitis C testing in needle and syringe exchange programs on linkage to care and treatment uptake among people who inject drugs: An Australian pilot study	6
A Programme of Hepatitis C Surveillance With Active Linkage to Care (HEAL) for Inpatients in Two Tertiary Hospitals in Jiangsu, China	6
Liver and cardiovascular mortality after hepatitis C virus eradication by DAA: Data from RESIST‐HCV cohort	6
Randomized clinical trial: Direct‐acting antivirals as treatment for hepatitis C in people who inject drugs: Delivered in needle and syringe programs via directly observed therapy versus fortnightly c	6
Issue Information	6
Early virologic relapse predicts alanine aminotransferase flares after nucleos(t)ide analogue withdrawal in patients with chronic hepatitis B	6
	6
Thrombospondin 2 as a Predictive Biomarker for HCC in Hepatitis C Patients: A Longitudinal Study Following DAA Therapy	6
Efficacy and Safety of Tenofovir Amibufenamide and Tenofovir Alafenamide for First‐Time HBV‐Related Decompensated Cirrhosis	6
Substance use and CD4/CD8 ratio in HIV/HCV co‐infected people receiving direct‐acting antiviral treatment (ANRS CO13 HEPAVIH): Authors' reply	6
Prognosis of hepatitis E infection in patients with chronic liver disease: A meta‐analysis	6
Incidence of post‐transplant hepatitis B virus reactivation with the use of kidneys from donors with resolved hepatitis B virus infection	5
Effectiveness of direct‐acting antiviral therapy among Aboriginal and Torres Strait Islander peoples with HCV infection in Australia: A national real‐world cohort (REACH‐C)	5
HBV pgRNA profiles in Chinese HIV/HBV coinfected patients under pre‐ and posttreatment: a multicentre observational cohort study	5
Patient‐reported outcomes of the Treatment and Prevention Study: A real‐world community‐based trial of direct‐acting antivirals for hepatitis C among people who inject drugs	5
Evolution and Impact of Hepatitis A Epidemiology in Europe—Systematic Literature Review of the Last 20 Years	5
Misuse of the Lower Limit of Detection in HBV DNA Testing and Anti‐HBe Positive Status Will Significantly Impact the Diagnosis of Occult HBV Infection	5
A Network Map of Intracellular Alpha‐Fetoprotein Signalling in Hepatocellular Carcinoma	5
Issue Information	5
Cure everyone and vaccinate the rest: The patient perspective on future hepatitis B treatment	5
Late presentation of chronic hepatitis C patients in the era of direct‐acting antivirals—Data from the German Hepatitis C‐Registry	5
Temporal and geographic spreading of hepatitis B virus genotype A (HBV‐A) in Brazil and the Americas	5
Migrants and hepatitis: A tale of two worlds	5
Testing to sustain hepatitis C elimination targets in people who inject drugs: A network‐based model	5
Psychiatrists can treat hepatitis C	5
Validation Study of Scores Predicting Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Treated With Nucleos(t)ide Analogues	5
Limited Value of HBV‐RNA for Relapse Prediction After Nucleos(t)ide Analogue Withdrawal in HBeAg‐negative Hepatitis B Patients	5
MiR‐155 regulates M2 polarization of hepatitis B virus‐infected tumour‐associated macrophages which in turn regulates the malignant progression of hepatocellular carcinoma	5
Knowledge, perception and expectation of management of hepatitis B infection among pregnant hepatitis B carriers in Hong Kong	5
Monkeypox outbreak as an opportunity to identify new cases of HCV infection in limited resource settings	5
Factors influencing compliance with Hepatitis C treatment in patients transitioning from prison to community—A summary scoping review	5
Mean HBsAg decline at week 24 of PEG‐IFN‐based treatment predicts subsequent rate of HBsAg clearance — suggesting a valuable endpoint for early development HBV trials	5
	5
	5
Impact of treatment with direct‐acting antivirals on inflammatory markers and autoantibodies in HIV/HCV co‐infected individuals	5
Reversibility of acute‐on‐chronic liver failure syndrome in hepatitis B virus‐infected patients with and without prior decompensation	4
Development of monoclonal antibodies to target the large surface protein of hepatitis B virus and their use in therapeutic and diagnostic applications	4
Prevalence of hepatitis C among pregnant women in an Appalachian population	4
Safety analysis of glecaprevir/pibrentasvir in patients with markers of advanced liver disease in clinical and real‐world cohorts	4
Issue Information	4
Modelling the potential impact of global hepatitis B vaccination on the burden of chronic hepatitis B in the United States	4
Geographic variation in HCV treatment penetration among people who inject drugs in Baltimore, MD	4
The tolerability of sofosbuvir/velpatasvir for 12 weeks in patients treated in the ASTRAL 1, 2 and 3 studies: A pooled safety analysis	4
	4
Elevation of S2‐bound α1‐acid glycoprotein is associated with chronic hepatitis C virus infection and hepatocellular carcinoma	4
Withdrawal: CircKIAA1429 accelerates hepatocellular carcinoma advancement by miR‐199b‐5p/OTX1 pathway, by Bin Lu, Min Cheng, Tao Wang	4
Safety, pharmacokinetics and antiviral activity of ABI‐H2158, a hepatitis B virus core inhibitor: A randomized, placebo‐controlled phase 1 study	4
Evaluating the prevalence of Hepatitis E virus infection in a large cohort of European blood donors, 2015–2018	4
	4
Hepatitis after gene therapy, what are the possible causes?	4
Issue Information	4
Health service utilization and experiences of stigma amongst people who inject drugs in Melbourne, Australia	4

Issue Information	4
Towards hepatitis C elimination in France: Scanvir, an effective model to test and treat drug users on dedicated days	4
	4
TRPM2 regulates autophagy to participate in hepatitis B virus replication	4
	4
Issue Information	4
Long‐term renal safety between patients with chronic hepatitis B receiving tenofovir vs. entecavir therapy: A multicenter study	4
Clinical impact of hepatic steatosis on chronic hepatitis B patients in Asia: A systematic review and meta‐analysis	4
Abnormal liver function tests and coronavirus disease 2019: A close relationship	4
Sex‐related difference analyses of efficacy and safety in clinical trials of direct‐acting antivirals to treat chronic HCV genotype 1 and 3 infections	4
Comment on ‘Long‐term prognosis with or without nucleot(s)ide analogue therapy in hepatitis B virus‐related decompensated cirrhosis’	4
Issue Information	4
Issue Information	4
Chronic viral hepatitis C micro‐elimination program using telemedicine in Guigang city	4
Context‐dependent accuracy of the cobas plasma separation card for HCV RNA viral load measurement	4
Prevalence and determinants of hepatitis delta virus infection among HIV/hepatitis B‐coinfected adults in care in the United States	4
Issue Information	4
Dynamic Changes in ELF Score Predict Hepatocellular Carcinoma in Chronic Hepatitis B Patients Receiving Antiviral Treatment	4
Soluble inflammatory mediators identify HCV patients who may be cured with four weeks of antiviral treatment	4
More intensive hepatitis C virus care models promote adherence among people who inject drugs with active drug use: The PREVAIL study	4
Perspectives of People Living With Chronic Hepatitis D: Impact of Disease and Unmet Needs Along the Care Cascade	4
	4
Issue Information	4
Shear wave elastography: How well does it perform in chronic hepatitis D virus infection?	4
Research progress on detection methods for hepatitis B virus covalently closed circular DNA	4
	4
Lower Serum Albumin Level: A Prospective Risk Predictor of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Virus Infection	4
Which patients should be considered for gene therapy	4